Literature DB >> 21258213

Virulence of serotype M3 Group A Streptococcus strains in wax worms (Galleria mellonella larvae).

Randall J Olsen1, M Ebru Watkins, Concepcion C Cantu, Stephen B Beres, James M Musser.   

Abstract

Group A Streptococcus (GAS) causes human infections that range in severity from pharyngitis ("strep-throat") to necrotizing fasciitis ("flesh-eating disease").  To facilitate investigation of the molecular basis of host-pathogen interactions, infection models capable of rapidly screening for differences in GAS strain virulence are needed.  To this end, we developed a Galleria mellonella larvae (wax worm) model of invasive GAS infection and used it to compare the virulence of serotype M3 GAS strains.  We found that GAS causes severe tissue damage and kills wax worms in a dose-dependent manner.  The virulence of genetically distinct GAS strains was compared by Kaplan-Meier survival analysis and determining 50% lethal doses (LD 50).  Host-pathogen interactions were further characterized using quantitative culture, histopathology and TaqMan assays.  GAS strains known to be highly pathogenic in mice and monkeys caused significantly lower survival and had significantly lower LD 50s in wax worms than GAS strains associated with attenuated virulence or asymptomatic carriage.  Furthermore, isogenic inactivation of proven virulence factors resulted in a significantly increased LD 50 and decreased lesion size compared to the wild-type strain, a finding that also strongly correlates with animal studies.  Importantly, survival analysis and LD 50 determination in wax worms supported our hypothesis that a newly emerged GAS subclone that is epidemiologically associated with more human necrotizing fasciitis cases than its progenitor lineage has significantly increased virulence.  We conclude that GAS virulence in wax worms strongly correlates with the data obtained in vertebrate models, and thus, the Galleria mellonella larva is a useful host organism to study GAS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21258213      PMCID: PMC3100763          DOI: 10.4161/viru.2.2.14338

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  50 in total

1.  Global profiling of Streptococcus pneumoniae gene expression at different growth temperatures.

Authors:  Utpal Pandya; Christopher A Allen; David A Watson; David W Niesel
Journal:  Gene       Date:  2005-09-08       Impact factor: 3.688

2.  Development of an insect model for the in vivo pathogenicity testing of yeasts.

Authors:  G Cotter; S Doyle; K Kavanagh
Journal:  FEMS Immunol Med Microbiol       Date:  2000-02

Review 3.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

4.  Involvement of both granular cells and plasmatocytes in phagocytic reactions in the greater wax moth, Galleria mellonella.

Authors: 
Journal:  J Insect Physiol       Date:  2000-07-01       Impact factor: 2.354

5.  Plasminogen is a critical host pathogenicity factor for group A streptococcal infection.

Authors:  Hongmin Sun; Ulrika Ringdahl; Jonathon W Homeister; William P Fay; N Cary Engleberg; Angela Y Yang; Laura S Rozek; Xixi Wang; Ulf Sjöbring; David Ginsburg
Journal:  Science       Date:  2004-08-27       Impact factor: 47.728

Review 6.  Streptococcus pyogenes and human neutrophils: a paradigm for evasion of innate host defense by bacterial pathogens.

Authors:  Jovanka M Voyich; James M Musser; Frank R DeLeo
Journal:  Microbes Infect       Date:  2004-10       Impact factor: 2.700

7.  A combination of independent transcriptional regulators shapes bacterial virulence gene expression during infection.

Authors:  Samuel A Shelburne; Randall J Olsen; Bryce Suber; Pranoti Sahasrabhojane; Paul Sumby; Richard G Brennan; James M Musser
Journal:  PLoS Pathog       Date:  2010-03-19       Impact factor: 6.823

8.  A chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response.

Authors:  Paul Sumby; Shizhen Zhang; Adeline R Whitney; Fabiana Falugi; Guido Grandi; Edward A Graviss; Frank R Deleo; James M Musser
Journal:  Infect Immun       Date:  2008-01-03       Impact factor: 3.441

9.  Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group.

Authors:  H D Davies; A McGeer; B Schwartz; K Green; D Cann; A E Simor; D E Low
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

10.  Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing.

Authors:  Michael M Mwangi; Shang Wei Wu; Yanjiao Zhou; Krzysztof Sieradzki; Herminia de Lencastre; Paul Richardson; David Bruce; Edward Rubin; Eugene Myers; Eric D Siggia; Alexander Tomasz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-21       Impact factor: 11.205

View more
  48 in total

Review 1.  Drosophila and Galleria insect model hosts: new tools for the study of fungal virulence, pharmacology and immunology.

Authors:  Michail S Lionakis
Journal:  Virulence       Date:  2011 Nov-Dec       Impact factor: 5.882

2.  Dissecting novel virulent determinants in the Burkholderia cepacia complex.

Authors:  George P Tegos; Mark K Haynes; Herbert P Schweizer
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

3.  All models are wrong, but some are useful: Averting the 'microbial apocalypse'.

Authors:  Siouxsie Wiles
Journal:  Virulence       Date:  2015       Impact factor: 5.882

4.  Biological Impact of a Large-Scale Genomic Inversion That Grossly Disrupts the Relative Positions of the Origin and Terminus Loci of the Streptococcus pyogenes Chromosome.

Authors:  Dragutin J Savic; Scott V Nguyen; Kimberly McCullor; W Michael McShan
Journal:  J Bacteriol       Date:  2019-08-08       Impact factor: 3.490

5.  Ceftaroline is active against heteroresistant methicillin-resistant Staphylococcus aureus clinical strains despite associated mutational mechanisms and intermediate levels of resistance.

Authors:  Regina Fernandez; Liliana I Paz; Roberto R Rosato; Adriana E Rosato
Journal:  Antimicrob Agents Chemother       Date:  2014-07-14       Impact factor: 5.191

6.  Polymorphisms in regulator of protease B (RopB) alter disease phenotype and strain virulence of serotype M3 group A Streptococcus.

Authors:  Randall J Olsen; Daniel R Laucirica; M Ebru Watkins; Marsha L Feske; Jesus R Garcia-Bustillos; Chau Vu; Concepcion Cantu; Samuel A Shelburne; Nahuel Fittipaldi; Muthiah Kumaraswami; Patrick R Shea; Anthony R Flores; Stephen B Beres; Maguerite Lovgren; Gregory J Tyrrell; Androulla Efstratiou; Donald E Low; Chris A Van Beneden; James M Musser
Journal:  J Infect Dis       Date:  2012-01-18       Impact factor: 5.226

Review 7.  Options and Limitations in Clinical Investigation of Bacterial Biofilms.

Authors:  Maria Magana; Christina Sereti; Anastasios Ioannidis; Courtney A Mitchell; Anthony R Ball; Emmanouil Magiorkinis; Stylianos Chatzipanagiotou; Michael R Hamblin; Maria Hadjifrangiskou; George P Tegos
Journal:  Clin Microbiol Rev       Date:  2018-04-04       Impact factor: 26.132

8.  New Shuttle Vectors for Real-Time Gene Expression Analysis in Multidrug-Resistant Acinetobacter Species: In Vitro and In Vivo Responses to Environmental Stressors.

Authors:  Massimiliano Lucidi; Daniela Visaggio; Elisa Prencipe; Francesco Imperi; Giordano Rampioni; Gabriella Cincotti; Livia Leoni; Paolo Visca
Journal:  Appl Environ Microbiol       Date:  2019-08-29       Impact factor: 4.792

9.  Construction and application of a luxABCDE reporter system for real-time monitoring of Enterococcus faecalis gene expression and growth.

Authors:  Sabina Leanti La Rosa; Dzung B Diep; Ingolf F Nes; Dag Anders Brede
Journal:  Appl Environ Microbiol       Date:  2012-07-27       Impact factor: 4.792

10.  The lysozyme-induced peptidoglycan N-acetylglucosamine deacetylase PgdA (EF1843) is required for Enterococcus faecalis virulence.

Authors:  Abdellah Benachour; Rabia Ladjouzi; André Le Jeune; Laurent Hébert; Simon Thorpe; Pascal Courtin; Marie-Pierre Chapot-Chartier; Tomasz K Prajsnar; Simon J Foster; Stéphane Mesnage
Journal:  J Bacteriol       Date:  2012-09-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.